Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration.
OBJECTIVE
We compared hemodynamic values, oxygen utilization, and adenine nucleotide concentration in the extracted organs of brain-dead donors treated with triiodothyronine vs. standard support treatment.


METHODS
Prospective, randomized, double-blind controlled study.


METHODS
We recruited 52 consecutive adult cadaveric organ donors. Inclusion criteria were diagnosis of brain-death, transplantation suitability, and family consent for donation; exclusion criterion was preexisting thyroid disease.


METHODS
The treatment group (n=29) received an intravenous bolus of 1 microg/kg triiodothyronine followed by continuous perfusion at 0.06 microg/kg per hour, and controls (n=23) received 0.9% ClNa delivered over 270 min. Hemodynamics, tonometry, thyroid hormones, and serum lactate were measured every 90 min from brain death to extraction procedure. Biopsies were processed to determine adenine nucleotides concentration.


RESULTS
Hemodynamic measurements did not differ significantly in the two groups, and the inotrope dose could not be diminished after treatment. Thyrotropin levels increased from brain death to extraction procedure in controls. Thyrotropin measured 90 and 180 min after the beginning of the perfusion was significantly lower in the treatment group than controls. The Pco2 gap increased in both groups from brain death to the extraction procedure. The lactate level of the treatment group was lower than in controls. Biopsy specimens were obtained in 19 controls and in 20 donors of the treatment group; the adenine nucleotides concentration did not show any significant difference.


CONCLUSIONS
Triiodothyronine did not add any benefit over the standard management of the organ donor nor did it affect the adenine nucleotides concentration of any biopsied organs.
Pérez-Blanco
Alicia
A
Unidad de Cuidados Intensivos, Hospital General de Elda, Ctra. de Elda a Sax, 03600 Elda Alicante, Spain. alipblanco@terra.es
Caturla-Such
Juan
J
Cánovas-Robles
José
J
Sanchez-Payá
José
J
D000227:Adenine Nucleotides / Q000378:metabolism*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001926:Brain Death / Q000378:metabolism*; D002302:Cardiac Output / Q000187:drug effects; D004311:Double-Blind Method; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D014019:Tissue Donors; D014284:Triiodothyronine / Q000494:pharmacology / Q000627:therapeutic use*
D000227:Adenine Nucleotides; D014284:Triiodothyronine; D019344:Lactic Acid